Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E- EPS (ttm)-1.25 Insider Own21.94% Shs Outstand93.70M Perf Week4.29%
Market Cap51.30M Forward P/E- EPS next Y-1.56 Insider Trans0.00% Shs Float73.14M Perf Month36.87%
Enterprise Value44.88M PEG- EPS next Q-0.29 Inst Own1.09% Short Float10.72% Perf Quarter134.38%
Income-21.74M P/S513.01 EPS this Y16.52% Inst Trans4.38% Short Ratio0.06 Perf Half Y-27.00%
Sales0.10M P/B1.32 EPS next Y-62.50% ROA-130.01% Short Interest7.84M Perf YTD-74.17%
Book/sh0.42 P/C6.33 EPS next 5Y- ROE-201.88% 52W High3.12 -82.45% Perf Year-65.99%
Cash/sh0.09 P/FCF- EPS past 3/5Y-220.46% -130.90% ROIC-289.64% 52W Low0.08 584.38% Perf 3Y-96.83%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-79.74% - Gross Margin100.00% Volatility9.41% 13.68% Perf 5Y-
Dividend TTM- EV/Sales448.81 EPS Y/Y TTM-3384.12% Oper. Margin-26535.71% ATR (14)0.09 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.12 Sales Y/Y TTM- Profit Margin-22186.73% RSI (14)49.48 Recom-
Dividend Gr. 3/5Y- - Current Ratio2.12 EPS Q/Q46.80% SMA20-1.46% Beta2.69 Target Price-
Payout- Debt/Eq0.23 Sales Q/Q- SMA50-0.77% Rel Volume0.28 Prev Close0.53
Employees9 LT Debt/Eq0.01 EarningsMay 15 BMO SMA200-40.00% Avg Volume127.26M Price0.55
IPOMar 02, 2022 Option/ShortNo / Yes EPS/Sales Surpr.56.52% 0.00% Trades Volume35,308,657 Change3.30%
Aug-31-25 05:41PM
Aug-26-25 08:00AM
Aug-22-25 08:00AM
Aug-19-25 04:29PM
Aug-17-25 01:56AM
08:00AM Loading…
Aug-08-25 08:00AM
Jul-31-25 08:00AM
Jul-30-25 08:00AM
Jul-25-25 07:30AM
Jun-24-25 07:30AM
Jun-18-25 07:30AM
Jun-17-25 07:30AM
Jun-12-25 07:30AM
Jun-03-25 07:30AM
May-29-25 07:30AM
04:21PM Loading…
May-28-25 04:21PM
07:00AM
May-20-25 07:30AM
May-16-25 09:00AM
May-15-25 08:00AM
May-14-25 08:00AM
Apr-03-25 07:30AM
Mar-07-25 02:10PM
Feb-18-25 05:52PM
Feb-14-25 07:30AM
Feb-04-25 09:15AM
Jan-23-25 07:30AM
Dec-02-24 04:48PM
Nov-14-24 04:05PM
Oct-24-24 07:30AM
04:50PM Loading…
Oct-02-24 04:50PM
Sep-30-24 04:01PM
Sep-10-24 08:00AM
Sep-09-24 08:00AM
Aug-05-24 07:30AM
Jul-30-24 07:30AM
Jul-01-24 07:37AM
Jun-27-24 07:34AM
May-30-24 07:30AM
May-07-24 07:30AM
May-01-24 02:33PM
Apr-16-24 08:00AM
Mar-24-24 07:55AM
Feb-28-24 07:30AM
Feb-16-24 07:30AM
Feb-01-24 07:30AM
Jan-24-24 04:05PM
Jan-18-24 08:22AM
Jan-17-24 07:30AM
Dec-21-23 04:05PM
Dec-06-23 07:30AM
Nov-29-23 01:40PM
Nov-16-23 08:30AM
Sep-08-23 07:30AM
Aug-24-23 01:15PM
07:30AM
Aug-23-23 11:45AM
Aug-22-23 07:30AM
Aug-08-23 08:00AM
Jul-28-23 07:30AM
Jul-27-23 01:20PM
Jul-26-23 07:30AM
Jul-21-23 09:09AM
Jul-18-23 02:30PM
07:40AM
Jul-13-23 08:00AM
Jul-11-23 03:00PM
Jul-10-23 07:30AM
Jul-06-23 08:42AM
Jun-23-23 08:00AM
Jun-19-23 11:20AM
Jun-16-23 08:00AM
Jun-01-23 12:15PM
May-30-23 08:00AM
May-16-23 07:50AM
May-05-23 07:30AM
May-03-23 02:20PM
07:30AM
May-02-23 07:30AM
Apr-25-23 08:00AM
Apr-14-23 07:30AM
Mar-16-23 08:51AM
Mar-15-23 12:55PM
07:30AM
Mar-03-23 01:30PM
07:30AM
Feb-28-23 05:30PM
07:25AM
Jan-18-23 08:00AM
Dec-06-22 08:00AM
Nov-29-22 08:00AM
Nov-28-22 08:00AM
Nov-17-22 08:00AM
Oct-28-22 08:00AM
Oct-13-22 08:00AM
Oct-11-22 08:00AM
Sep-08-22 09:15AM
Aug-17-22 08:00AM
Aug-10-22 04:36PM
Aug-02-22 07:55AM
Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on July 5, 2023 and is headquartered in Norwest, Australia.